Medindia
Medindia LOGIN REGISTER
Advertisement

Cardiac Science Announces Data Connectivity with LUMEDX

Thursday, October 18, 2007 General News
Advertisement
BOTHELL, Wash., Oct. 17 Cardiac ScienceCorporation (Nasdaq: CSCX), a global leader in advanced cardiac monitoring anddefibrillation products, announced today that its new cardiac rehab system, Q-Tel RMS(R) 3.0, now has seamless connectivity with LUMEDX CardioWellness(TM)data management software.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)

The integration of rehabilitation data from the Q-Tel RMS 3.0 system intoCardioWellness enables the best possible treatment decisions. The combinationallows caregivers to seamlessly integrate data from the Q-Tel RMS 3.0rehabilitation system into CardioWellness, creating a comprehensive diagnosisand treatment plan tuned specifically to the patient's gender specific needs.By applying this gender-specific understanding of the patient's disease stateto the rehabilitation treatment, outcomes can be improved.
Advertisement

"Cardiac Science is dedicated to helping its customers improve theirworkflows and improve access to data, facilitating the best possible treatmentdecisions," said René Mitchell, director of diagnostic marketing at CardiacScience. "In response to feedback from clinicians, the Q-Tel RMS 3.0 featuresenhanced connectivity capabilities to improve rehab center workflow, whilemaintaining the heritage of reliability and high performance of the Q-Telfamily of rehabilitation management systems. We believe that thiscollaboration with LUMEDX will improve patient care and better meet the needsof our customers."

"CardioWellness can help facilities grow their gender-specificcardiovascular care programs with its sophisticated database for trackingpatients from risk assessment through treatment," said Randy Marc Lasnick,director of marketing at LUMEDX Corporation. "Research has shown that gender-specific care can provide patients with better outcomes. We believe that byproviding a direct link between CardioWellness and Q-Tel RMS 3.0, the leadingcardiac rehabilitation system, we can provide greater value to thesefacilities by bringing an added layer of critical rehab data into the clinicaldecision making process."

Frost & Sullivan, the global growth consulting company, has awardedCardiac Science its 2007 award for Global Excellence in ECG Monitoring,recognizing Cardiac Science's superior leadership and vision to providesuperior healthcare solutions in the cardiac monitoring market.

For more information about the Q-Tel RMS 3.0, please call 800.679.8703.

About LUMEDX

Founded in 1990, LUMEDX is the market leader in developing end-to-endcardiovascular information and imaging systems. Providing consulting services,training, and the CardioStar(TM) software suite-the most comprehensive suiteof fully integrated cardiovascular information tools-LUMEDX delivers completeclinical and business solutions for heart centers.

About CardioWellness

CardioWellness is a comprehensive set of tools and support programs tohelp heart centers grow their own successful gender-specific CV centers.CardioWellness recognizes the differences in presentation, diagnostic testing,risk assessment, and outcomes for men and women. These differences are builtinto the way patients are diagnosed, treated, and tracked throughout thecontinuum of care.

About Q-Tel RMS 3.0

The Q-Tel RMS system is a state-of-the-art, comprehensive cardiacmonitoring and data management system developed to meet the needs of cardiacrehabilitation programs. Designed with efficient workflow and integration toEMR and HIS systems in mind, the Q-Tel family of Rehabilitation ManagementSystems is designed to enable the best possible treatment decisions.

About Cardiac Science Corporation

Cardiac Science is truly at the heart of saving lives. The Companydevelops, manufactures, and markets a family of advanced diagnostic andtherapeutic cardiology devices and systems, including AEDs
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close